Katherine Stueland [CNBC]
Opko Health, Inc. (OPK)
Last opko health, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.opko.com
Company Research
Source: CNBC
Notable in 2024: Stueland introduced new innovations in genomic sequencing, accelerating diagnosis and expanding to new areas, including pediatric and newborn screening. Katherine Stueland has worked in pharmaceutical positions related to some of the biggest breakthroughs in recent decades, from the first protease inhibitor for HIV/AIDS to novel cancer immunotherapy. Now, the health-care challenge she is tackling from the top of a growing biotech is to increase use of genetic information in identifying and treating rare diseases, in particular among children and newborns. As chief executive officer at GeneDx since June 2021 , Stueland oversees one of the largest rare disease databases in the world, tripling the patients that the company has seq
Read more
Impact Snapshot
Event Time:
OPK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OPK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OPK alerts
High impacting Opko Health, Inc. news events
Weekly update
A roundup of the hottest topics
OPK
News
- GeneDx to Acquire Fabric Genomics, Enabling Decentralized, AI-Powered Testing at Global Scale [Yahoo! Finance]Yahoo! Finance
- IBD 50's GeneDx Inks $84 Million AI-Tied Takeover Deal [Yahoo! Finance]Yahoo! Finance
- At a family reunion she discovered multiple relatives had cystic fibrosis. Decades later she's built a $2.6 billion genetic testing company [Yahoo! Finance]Yahoo! Finance
- Work at Fortune [Fortune]Fortune
- OPKO Health, Inc. (NASDAQ: OPK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.MarketBeat
OPK
Earnings
- 2/27/25 - Beat
OPK
Sec Filings
- 4/10/25 - Form 4
- 4/8/25 - Form 4
- 4/3/25 - Form SCHEDULE
- OPK's page on the SEC website